Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT01890161
A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2013
Completion: Apr 30, 2014